Regulatory affairs is the function within a pharmaceutical company responsible for getting drugs approved by government agencies and keeping them in compliance once they reach the market. Every prescription medication, over-the-counter drug, biologic, and generic sold legally must first clear a regulatory review process, and the regulatory affairs team manages that process from early development through the entire commercial life of the product.
What Regulatory Affairs Teams Actually Do
At its core, regulatory affairs is the bridge between a drug company and the government agencies that decide whether a product is safe and effective enough to sell. The work touches nearly every stage of a drug’s lifecycle. During early development, regulatory professionals advise scientists and executives on what data the company will need to collect, what legal and scientific requirements apply, and how to design studies that will satisfy regulators. This strategic input happens at the highest levels of the organization and directly shapes whether a development program succeeds or fails.
Once a drug candidate moves into clinical trials, the regulatory team prepares and submits the formal applications that allow testing in humans. In the United States, that means filing an Investigational New Drug Application (IND) with the FDA. The team collects, organizes, and evaluates the scientific data generated during trials, then assembles it into a registration dossier, a massive document package that can run tens of thousands of pages. For a finished product seeking U.S. approval, this takes the form of a New Drug Application (NDA) for standard pharmaceuticals, an Abbreviated New Drug Application (ANDA) for generics, or a Biologics License Application (BLA) for vaccines, gene therapies, and other biological products.
After submission, the work is far from over. Regulatory professionals negotiate directly with agency reviewers, respond to questions, provide additional data, and advocate for the product through what can be a months-long review cycle. Once a drug is approved and on the market, the team monitors changing regulations across every country where the product is sold, manages required post-market safety reports, and ensures the company maintains its marketing authorization. They also commonly review product packaging, labeling, and advertising materials before anything goes public, making sure all claims stay within what regulators have approved.
Key Regulatory Agencies and Submissions
Pharmaceutical companies that sell globally must navigate a different regulatory agency in nearly every major market. The FDA oversees the United States. The European Medicines Agency (EMA) coordinates drug approvals across EU member states through what’s called a Marketing Authorisation Application (MAA). Other major bodies include Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), China’s National Medical Products Administration (NMPA), and Health Canada. Each agency has its own rules, timelines, and expectations, which is why regulatory teams often include specialists dedicated to specific regions.
To standardize the submission process across borders, the industry uses a format called the Electronic Common Technical Document (eCTD). The FDA accepts eCTD submissions for NDAs, ANDAs, INDs, BLAs, drug and biologics master files, and Emergency Use Authorizations. The eCTD organizes clinical, nonclinical, and manufacturing data into a common structure so that a single data set can, with some adaptation, support filings in multiple countries. Regulatory professionals need to be fluent in this format and understand the technical requirements for each agency they submit to.
Where Regulatory Affairs Fits in a Company
Regulatory affairs sits at the intersection of science, law, and business strategy. The team works closely with research and development scientists designing studies, with manufacturing teams documenting how drugs are produced, with legal counsel interpreting regulations, and with commercial teams planning product launches. A regulatory professional might spend the morning reviewing clinical trial protocols with a medical director and the afternoon advising the marketing department on what claims can legally appear in an advertisement.
Because a single regulatory misstep can delay a product launch by months or years, costing a company hundreds of millions of dollars in lost revenue, the department carries significant influence. Regulatory leaders often report directly to senior executives and sit on product development committees. Their judgment on timing, data requirements, and submission strategy shapes billion-dollar decisions about which drugs move forward and which get shelved.
Typical Roles and Career Path
Most people enter regulatory affairs with a science background. A bachelor’s degree in pharmacy, chemistry, biology, or a related field is the standard starting point. From there, the career ladder typically moves from regulatory affairs associate or coordinator, handling document preparation and tracking submissions, to regulatory affairs specialist, managing portions of a submission independently, to senior specialist or manager, overseeing entire product filings and leading agency interactions.
At the top, directors and vice presidents of regulatory affairs set department-wide strategy, represent the company in high-stakes agency meetings, and make decisions about global filing timelines. Some regulatory professionals specialize by function (labeling, advertising review, post-market compliance) or by product type (oncology drugs, biologics, generics).
The leading professional credential in the field is the Regulatory Affairs Certification (RAC), offered by the Regulatory Affairs Professionals Society (RAPS). The pharmaceutical-specific designation is called RAC-Drugs. To sit for the exam, you need a bachelor’s degree plus at least three years of regulatory or related experience, a master’s degree plus two years, a doctorate plus one year, or ten years of relevant experience without a formal degree. Related experience can include quality assurance, quality control, clinical research, or health product project management. Earning the RAC signals to employers that you understand the regulations and can think critically about the challenges that arise throughout a product’s lifecycle.
Skills That Matter Most
Regulatory affairs demands a somewhat unusual combination of abilities. You need enough scientific literacy to understand clinical data, pharmacology, and manufacturing processes. You need strong writing skills because the submissions you prepare must be precise, well-organized, and persuasive. Attention to detail is non-negotiable: a single data inconsistency or formatting error in a filing can trigger review delays.
Beyond the technical side, regulatory professionals need strategic thinking. Choosing the right regulatory pathway for a product, deciding when to meet with an agency, and knowing how to frame data in the most favorable (but honest) light are judgment calls that come with experience. Communication skills matter because you’re constantly translating between scientists who speak in data, executives who speak in timelines and revenue, and regulators who speak in legal requirements. The ability to track and interpret evolving legislation across multiple countries is also essential, since regulations change frequently and missing a new requirement can have serious consequences.
How the Field Is Evolving
Pharmaceutical regulatory affairs is becoming more complex and more technology-driven. The FDA’s 2026 regulatory education conference highlights several areas reshaping the field: the use of artificial intelligence to accelerate drug development, digital health technologies for collecting clinical trial data (like wearable devices and remote monitoring), and advanced manufacturing techniques that require new regulatory frameworks.
AI tools are beginning to assist with tasks like literature reviews, signal detection in safety data, and even drafting portions of regulatory documents. Digital health technologies are generating new types of clinical evidence that regulators are still learning how to evaluate. For professionals in the field, this means the job increasingly requires comfort with data science concepts and digital tools alongside traditional regulatory knowledge. Companies are looking for regulatory specialists who can help them navigate not just existing rules but the gray areas where regulation hasn’t caught up to the technology yet.
Salary and Job Outlook
Regulatory affairs roles tend to pay well, reflecting the specialized knowledge required. Entry-level associates and coordinators typically start in the $55,000 to $75,000 range, while experienced specialists with five to ten years of experience commonly earn $90,000 to $130,000. Senior managers and directors at large pharmaceutical companies can earn $150,000 to $200,000 or more, particularly in major biotech hubs.
Demand for regulatory professionals remains strong. As long as governments require drug companies to prove their products are safe and effective before selling them, and as long as those requirements keep growing more complex, companies will need people who can navigate the system. The expansion of biological products, gene therapies, and personalized medicines has created new regulatory challenges that require specialized expertise, further broadening the opportunities available in the field.